Repaglinide/Rosiglitazone combination therapy of type 2 diabetes

被引：0
|
作者：
Raskin, P
McGill, J
Hale, P
Khutoryansky, N
Santiago, O
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A128 / A129
页数：2
相关论文
共 50 条
  • [31] Metformin/rosiglitazone combination pill (Avandamet®) for the treatment of patients with Type 2 diabetes
    Smiley, Dawn
    Umpierrez, Guillermo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1353 - 1364
  • [32] Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes
    Vilar, Lucio
    Canadas, Viviane
    Arruda, Maria Juliana
    Arahata, Carla
    Agra, Rodrigo
    Pontes, Lisete
    Montenegro, Larissa
    Vilar, Clarice Freitas
    Moura e Silva, Lidiane
    Albuquerque, Jose Luciano
    Gusmao, Amaro
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (03) : 311 - 318
  • [33] Metformin/Repaglinide (PrandiMet) for Type 2 Diabetes
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1313): : 41 - 43
  • [34] Repaglinide-metformin combination in the treatment of type 2 diabetes:: Comparison between three different combination regimens
    Barone, M
    Aiello, A
    Allochis, G
    Borzì, V
    Cannatà, E
    Caronna, S
    D'Avanzo, A
    Elli, P
    Formoso, G
    Paroli, A
    Scardapane, R
    Sorichetti, P
    Tatti, P
    Viviani, G
    Santeusanio, F
    [J]. DIABETOLOGIA, 2004, 47 : A15 - A15
  • [35] Combination therapy options for type 2 diabetes
    Laffman-Johnson, Elise
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (06) : 618 - 618
  • [36] Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
    Rosenstock, J.
    Rood, J.
    Cobitz, A.
    Biswas, N.
    Chou, H.
    Garber, A.
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 650 - 660
  • [37] Initial Combination Therapy in Type 2 Diabetes
    Kim, Ji Yoon
    Kim, Nam Hoon
    [J]. ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 23 - 32
  • [38] Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries, Corinne S.
    Russell-Jones, David L.
    [J]. BRITISH MEDICAL JOURNAL, 2009, 339
  • [39] Oral combination therapy for type 2 diabetes
    Charpentier, G
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 : S70 - S76
  • [40] An alternative combination therapy for type 2 diabetes?
    Ostoft, Signe H.
    Christensen, Mikkel
    [J]. LANCET, 2015, 385 (9982): : 2020 - 2022
12345